Back to search

National and Kapodistrian University of Athens

Synthesis of (DHEA) derivatives substituted by four, five or six membered-17-spiro substituents

Abstract

dc:description

Neurodegenerative diseases pose significant challenges worldwide, contributing to high mortality rates. Conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and multiple sclerosis are characterized by progressive disruption of normal neuronal structure and function, accompanied by oxidative and inflammatory stress. Dysregulation of the neuro-trophin system has been identified as a common factor in these neurodegenerative diseases, highlight-ing its crucial role in the development, functioning, and overall health of the nervous system. This thesis is focused on the agonism of neurotrophin receptors TrkA and TrkB as a potential therapeu-tic approach to slow down the neurodegenerative process and enhance patients' quality of life and life expectancy. The natural ligands for these receptors, though effective, face limitations as drugs due to their large peptidic structure, short half-life, and potential side effects. Hence, the need arises for small, metabolically stable neurotrophin mimetics. Building upon the neurotrophin receptor agonistic activity of the endogenous steroid dehydroepi-androsterone (DHEA), the research group of Dr Calogeropoulou designed and synthesized BNN27, a potent selective TrkA activator that served as the foundation for this thesis. BNN27's success stemmed from the incorporation of a delicate spiro-epoxide ring at position C17. To develop more metabolically stable derivatives while enhancing activity and selectivity towards neurotrophin receptors, this project aimed to substitute BNN27's spiro-epoxide with 4-, 5-, and 6-membered rings. Additionally, various substituents were introduced to probe the optimal stereo-electronic requirements for the activation of neurotrophin receptors TrkA and TrkB and obtain structure-activity relationships. Consequently, a total of 29 C17-spiro-ring-substituted DHEA derivatives were synthesized as potential novel small neurotro-phin mimetics. The new compounds were evaluated for their neuroprotective activities through interaction with the neurotrophin receptors TrkA and/or TrkB, by assessing their ability to induce the phosphorylation of TrkA, TrkB, and activation of downstream cascade proteins Akt and ERK1/2 in PC12, primary astrocytes and NIH-3T3-TrkB cell lines. The compounds' potential to limit neuroinflammatory responses in primary microglia was also investigated. Additionally, the ADME-Tox profiles of the most potent derivatives were determined, including their metabolic stability in human liver microsomes and their potential to inhibit major P450 cytochromes. This study offers valuable insights into neurotrophin receptor agonism and the activity of the synthe-sized compounds. ENT-A025 emerged as a potent TrkA activator, displaying comparable phosphoryla-tion levels to NGF. Several derivatives, such as ENT-A065, ENT-A066, ENT-A068, ENT-A069, and ENT-A070, demonstrated pro-survival effects in TrkA-expressing cell lines. Promising TrkB agonists were identified among the tested compounds, including ENT-A009, ENT-A055, ENT-A075, ENT-A076, and ENT-A087. All compounds exhibited favourable ADME-Tox profiles and drug-like qualities; however, they didn’t exhibit any anti-neuroinflammatory effect.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Narducci, Daniele
  • Ναρντούτσι, Ντανιέλε

Subjects

dc:subject × 22

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58884

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Narducci, Daniele; Ναρντούτσι, Ντανιέλε. Synthesis of (DHEA) derivatives substituted by four, five or six membered-17-spiro substituents. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/58884